Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$3.05 USD
-0.06 (-1.93%)
Updated May 23, 2024 04:00 PM ET
After-Market: $3.04 -0.01 (-0.33%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, Galectin Therapeutics (GALT) reported earnings of -$0.19 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 18.75%. Look out for GALT's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 6.67%.
Earnings History
Price & Consensus
Zacks News for GALT
What Makes Galectin Therapeutics Inc. (GALT) a New Buy Stock
GALT: What are Zacks experts saying now?
Zacks Private Portfolio Services